Table 3:

Neuropathological assessment of amyloid β deposits (A), staging of neurofibrillary tangles (B), and scoring of neuritic plaques (C)^*, as well as Braak and Braak^** staging for specimen of mutation carriers

Case	A	B	C	Braak & Braak
Case 1024	3	3	3	VI
Case 4121	3	3	3	VI
Case 8382	3	3	3	VI
Case 697	3	3	3	VI

Note:

¹Staging performed in 1996;

²No official score available for CASE 838, provided staging indicates an estimate by the pathologist.

^*(Montine et al., 2012);

^**(Braak et al., 2011)